Cargando…

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

Ovarian hyperstimulation syndrome (OHSS) is a life- threatening complication of controlled ovarian stimulation. One of the main symptoms of OHSS is ascites. Treatment is symptomatic with resolution of the symptoms over days to weeks. We report a case of severe OHSS with persistent ascites 18 months...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comba, Cihan, Ugurlucan, Funda Gungor, Bastu, Ercan, Iyibozkurt, Ahmet Cem, Topuz, Samet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889824/ https://www.ncbi.nlm.nih.gov/pubmed/23846619 http://dx.doi.org/10.1007/s00404-013-2940-7

Ejemplares similares

Nephrotic Sydrome Developing in Severe Ovarian Hyperstimulation Syndrome
por: Gungor Ugurlucan, Funda, et al.
Publicado: (2014)

Efficacy of endocervical curettage and CA-125 measurement in endometrial serous carcinoma: A case series and literature review
por: İyibozkurt, Ahmet Cem, et al.
Publicado: (2015)

Comparison of Ovulation Induction Protocols After Endometrioma Resection
por: Bastu, Ercan, et al.
Publicado: (2014)

Reproductive Outcomes of Hysteroscopic Septoplasty Techniques
por: Dural, Ozlem, et al.
Publicado: (2015)

Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases
por: Gürbüz, Ali Sami, et al.
Publicado: (2020)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Effect of Lymphadenectomy on Survival in Early-Stage Type II Endometrial Carcinoma and Carcinosarcoma
por: Vatansever, Dogan, et al.
Publicado: (2020)

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
por: Ingold, Caroline, et al.
Publicado: (2023)

Spontaneous bacterial peritonitis complicating ovarian hyperstimulation syndrome-related ascites
por: Taniguchi, Leandro Utino, et al.
Publicado: (2011)

Symptoms and Health Quality After Laparoscopic and Robotic Myomectomy
por: Takmaz, Ozguc, et al.
Publicado: (2018)

The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
por: Dolgun, Zehra Nihal, et al.
Publicado: (2017)

Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?
por: Gurbuz, Ali Sami, et al.
Publicado: (2016)

Approach to Abnormal Uterine Bleeding in Adolescents
por: Yaşa, Cenk, et al.
Publicado: (2020)

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
por: O’Brien, Travis J, et al.
Publicado: (2013)

The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
por: Chappell, Neil, et al.
Publicado: (2017)

Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy
por: Ramachandran, Amar, et al.
Publicado: (2013)

Ovarian hyperstimulation syndrome and pregnancy luteoma mimicking malignant ascites: a rare case report
por: Chen, Jing, et al.
Publicado: (2023)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy
por: Hatzipetros, Ioannis, et al.
Publicado: (2013)

Gonadotropin-releasing Hormone Agonist Overuse: Urologists’ Response to Reimbursement and Characteristics Associated with Persistent Overuse
por: Ellis, Shellie D., et al.
Publicado: (2015)

Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial
por: Engmann, L. L., et al.
Publicado: (2019)

Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series
por: Lee, Dayong, et al.
Publicado: (2017)

A Rare Dermatologic Disease in Pregnancy: Rosacea Fulminans- Case Report and Review of the Literature
por: Demir, Omer, et al.
Publicado: (2018)

Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome
por: Orkunoglu-Suer, Funda, et al.
Publicado: (2015)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

Blastocyst transfer does not improve cycle outcome as compared to D3 transfer in antagonist cycles with an elevated progesterone level on the day of hCG
por: Demirel, Cem, et al.
Publicado: (2017)

Diagnosis and management of vulvar Darier disease: A case report
por: Evruke, Ipek, et al.
Publicado: (2023)

BILATERAL PLEURAL EFFUSIONS WITHOUT SIGNIFICANT ASCITES IN AN OVARIAN HYPERSTIMULATION PATIENT RECOVERED FROM COVID-19: A CASE REPORT
por: Anderson, Kelsey L., et al.
Publicado: (2021)

Gonadotropin-releasing hormone agonist-induced pituitary apoplexy
por: Keane, Fergus, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
por: Shiasi Arani, Kobra, et al.
Publicado: (2015)

Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021)

Successful pregnancy after presurgical uterine artery embolization in the management of a very large cervical myoma: A case report
por: Akhan, Suleyman Engin, et al.
Publicado: (2022)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
por: Kojima, Nobue, et al.
Publicado: (2018)

Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger)
por: de Oliveira, Sofia Andrade, et al.
Publicado: (2016)

Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats
por: TUNGMAHASUK, Doungrut, et al.
Publicado: (2017)

Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
por: Halim, Binarwan, et al.
Publicado: (2022)

Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors
por: Finch, Ann R., et al.
Publicado: (2009)

The role of gonadotropin-releasing hormone agonists in female fertility preservation
por: Lee, Jae Hoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d74f3rmlce7oui7b0bl27cip0l